Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bordier

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
European Journal of Pharmacology|April 11, 1996
Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitroA Boireau, C Malgouris, M C Burgevin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosisT Canton, G A Böhme, A Boireau, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
European Journal of Pharmacology|April 11, 1996
Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitroA Boireau, C Malgouris, M C Burgevin, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosisT Canton, G A Böhme, A Boireau, et al.
Pageof 2